The impacted products have now been given a Class I risk classification by the U.S. Food and Drug Administration.
Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.
In October, the FDA in collaboration with the U.S. Customs and Border Protection (CBP), seized about three million units of ...
A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...
With Donald Trump taking office and Robert F. Kennedy Jr. poised to assume the nation’s top health role, it seems the agency ...
After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...
The Food and Drug Administration (FDA) will begin collecting samples of raw cow’s milk cheese from across the U.S. to test ...
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
President-elect Donald Trump and his nominee to run the U.S. Department of Health and Human Services, Robert F. Kennedy Jr., ...